Where Opportunity Is Found - Research & Analysis on American Capital Agency Corp. and Medtronic, Inc.

HONG KONG, Jun 18 (Marketwire) --
This morning, www.MarketFoundations.com announced new reports
highlighting American Capital Agency Corp. (NASDAQ: AGNC) and Medtronic,
Inc. (NYSE: MDT). Free research downloads are available at
www.MarketFoundations.com/index.php?coa=AGNC&cob=MDT.

With markets in correction mode, investors are looking to quantify an
accurate model, weighing positives and negatives of the months ahead.
Upcoming negative pressures include China's slowdown, the European
recession, the end of the Fed's Operation Twist stimulus program,
continued geopolitical risks, election uncertainty, and potential 2013
budget bombshell of tax hikes and spending cuts. Meanwhile, positive
offsets are driven by central banks (particularly China) cutting rather
than hiking rates, deceleration in fuel and food prices, increase in
consumer sentiment and resulting retail sales, signs of improvement in
housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high
momentum situations with growth potential -- there remains strong
opportunity within careful discretion.

Market Foundations is releasing new coverage on American Capital Agency
Corp. for its current position within the financial industry. American
Capital Agency Corp. (AGNC) is a real estate investment trust (REIT). The
Company earns income primarily from investing on a leveraged basis in
agency mortgage-backed securities. The full research report on American
Capital Agency Corp. (NASDAQ: AGNC) is available here:
www.MarketFoundations.com/index.php?coa=AGNC.

Market Foundations has released research on Medtronic, Inc. for its
changing role within the healthcare industry. Medtronic, Inc. (Medtronic)
is engaged in the medical technology -- alleviating pain, restoring
health, and extending life for people with chronic conditions worldwide.
Medtronic develops and manufactures a range of products and therapies
providing a continuum of care to diagnose, prevent and monitor chronic
conditions. On January 13, 2011, the Company acquired Ardian, Inc. The
full research report on Medtronic, Inc. (NYSE: MDT) is available here:
www.MarketFoundations.com/index.php?cob=MDT.

About Market Foundations
By providing members with financial information
services, we provide the foundation investors need to build investing
intelligence. The difference between consistently making good investments
or bad investments is nothing more than the right information at the
right time.

Contact:

Gemma Cunningham
contact@MarketFoundations.com
www.MarketFoundations.com

Copyright 2012, Marketwire, All rights reserved.

-0-